BioSpace News Archive

Gene expression is a process that results in the synthesis of a functional gene product with the help of the information coded on genes.

An expression vector is also called an expression construct and is usually a plasmid derivative designed for protein expression in cells.

The Fact MR survey on behavioral health treatment market offers detailed analysis on the key growth drivers and trends affecting demand in the market.

Active Biotech provided information that its partner in the naptumomab project, NeoTX will host a key opinion leader webinar on overcoming checkpoint inhibitor resistance on Wednesday, July 14th at 10 am eastern time

The development program focuses on the treatment of immunocompromised patients whose herpes simplex virus (HSV) infections have become resistant to acyclovir The phase 2 part of the trial showed strong clinical efficacy and confirmed the good safety profile of pritelivir already seen in earlier phase 2 trials The clinical trial was immediately amended and a pivotal phase 3 part becoming the basis for NDA submission has started WUPPERTAL, GERMANY / ACCESSWIRE / July 8, 2021 / AiCu

Dante Labs announced the launch of Stripe2be, a platform and business unit fully dedicated to rare disease patients, offering personalized, AI-driven reports based on Whole Genome Sequencing and leveraging Dante Labs’ CE-IVD, ISO13485 certified Immensa Genomic Interpretation Software.

On 21 July, at 08:00 CEST, Swedish Orphan Biovitrum AB will publish its report for the second quarter 2021.

Evaxion Biotech A/S, a clinical-stage biotech company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced results from both its Phase 1/2a trial of cancer immunotherapy EVX-01 in metastatic melanoma and interim Phase 1/2a trial of cancer immunotherapy EVX-02 in adjuvant melanoma.

Exact Sciences Corp. announced that the company plans to release its second quarter 2021 financial results after the close of the U.S. financial markets on July 28, 2021.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release second quarter 2021 operating results after the close of the market on Wednesday, August 4, 2021.